簡(jiǎn)要描述:Illumina 測(cè)序試劑盒 RS-122-2002上海易匯生物科技有限公司于17年正式銷售Illumina公司基因芯片、二代測(cè)序NGS測(cè)序儀及相關(guān)測(cè)序試劑盒等產(chǎn)品Illumina/TruSeq RNA Library Preparation Kit v2, Set B (48 samples, 12 indexes)/RS-122-2002/1 Ea
相關(guān)文章
Related Articles詳細(xì)介紹
品牌 | illumina/美國(guó)因美納 | 貨號(hào) | RS-122-2002 |
---|---|---|---|
規(guī)格 | 1 kit | 供貨周期 | 兩周 |
主要用途 | 小型全基因組測(cè)序 組合試劑 試劑盒 | 應(yīng)用領(lǐng)域 | 醫(yī)療衛(wèi)生,化工,生物產(chǎn)業(yè),制藥 |
Illumina 測(cè)序試劑盒 RS-122-2002
Illumina/TruSeq RNA Library Preparation Kit v2, Set B (48 samples, 12 indexes)/RS-122-2002/1 Ea
產(chǎn)品編號(hào): RS-122-2002
美 元 價(jià): $3591.00
會(huì) 員 價(jià): 待定
品 牌: Illumina
產(chǎn) 地: 美國(guó)
公 司: Illumina, Inc.
產(chǎn)品分類: 分子類>二代測(cè)序>DNA文庫(kù)制備試劑盒
公司分類: Library Preparation Kits
Illumina公司創(chuàng)立于1998年4月,是遺傳變異和生物學(xué)功能分析領(lǐng)域的優(yōu)秀的產(chǎn)品、技術(shù)和服務(wù)供應(yīng)商。通過幫助客戶加快實(shí)現(xiàn)生物信息的采集、分析和應(yīng)用,來改善人類健康。
Sequencing Kits/ Microarray Kits/Informatics Products/ Clinical Research Products/In Vitro Diagnostic/ Products/Molecular Biology Reagents/ Accessory Products
Product Highlights:
Generate mRNA-focused sequencing libraries from total RNA, with enhanced multiplex capABIlity and a simplified workflow with master-mixed reagents.
Kits feature 24 unique indexes, delivering enhanced multiplex performance for processing large numbers of samples (including up to 384 RNA-Seq samples on a single HiSeq 2500 System run).
Master-mixed reagents eliminate the majority of pipetting steps and reduce the amount of clean-up, as compared to previous methods, minimizing hands-on time. This results in economical, high-throughput RNA sequencing studies achieved with the easiest-to-use sample preparation workflow offered by any NGS platform.
Find an up-to-date list of high-throughput automation vendors with robotic systems compatIBLe with this library preparation kit
Specifications:
Assay Time | ~10.5 hours |
Hands-On Time | ~4.5 hours |
Input Quantity | 0.1 - 1 ug total RNA or 10 - 400 ng previously isolated mRNA (from species with polyA tails) |
Content Specifications | Captures the coding transcriptome (without strand information) |
Mechanism of Action | Oligo-dT beads capture polyA tails |
Multiplexing | Up to 24-plex per lane |
System Compatibility | Genome Analyzer IIx,HiSeq 2000,MiSeq,NextSeq 550,HiSeq 3000,HiSeq 1000,HiSeq 1500,NextSeq 500,HiSeq 2500,HiSeq 4000 |
Species Category | Other,Mammalian,Bovine,Mouse,Human,Rat |
Variant Class | Single Nucleotide Polymorphisms (SNPs),Gene Fusions,Novel Transcripts,Transcript Variants |
Technology | Sequencing |
Method | mRNA Sequencing |
Automation CapABIlity | Liquid Handling Robots |
上海易匯生物科技有限公司于17年正式銷售Illumina公司基因芯片、二代測(cè)序NGS測(cè)序儀及相關(guān)測(cè)序試劑盒等產(chǎn)品
咨詢illumina MiSeq測(cè)序試劑盒等產(chǎn)品歡迎您致電 上海易匯生物科技有限公司:1850 1609 238張經(jīng)理
Illumina公司,致力于新一代測(cè)序和芯片技術(shù)的生產(chǎn)與開發(fā),提供的產(chǎn)品與應(yīng)用資訊。Illumina公司創(chuàng)立于1998年4月,是遺傳變異和生物學(xué)功能分析領(lǐng)域的優(yōu)秀的產(chǎn)品、技術(shù)和服務(wù)供應(yīng)商。通過幫助客戶加快實(shí)現(xiàn)生物信息的采集、分析和應(yīng)用,來改善人類健康。
As a startup, Illumina aspired to transform human health. Our initial products enabled researchers to explore DNA at an entirely new scale, helping them create the first map of gene variations associated with health, disease, and drug response. Every breakthrough opened up a new world, and showed us how much further there is to go
While the rate of progress is accelerating exponentially, we are only beginning to understand the clinical significance of the genome. What causes a cancer cell to mutate? What is the origin of a puzzling disease? Is it possible to prevent the next outbreak? Or safeguard the world’s food supply? These are just a few of the challenges that inspire us to push the boundaries of our imagination
Today we are a global leader in genomics – an industry at the intersection of biology and technology. At the most fundamental level, we enable our customers to read and understand genetic variations. We strive to make our solutions increasingly simple, more accessible, and always reliable. As a result, discoveries that were unimaginable even a few years ago are now becoming routine – and are making their way into patient treatment.
We now have the ability to sequence at an unprecedented scale. Collectively, this will give us a much deeper understanding of genetics than ever before. We will begin to truly unlock the power of the genome. These advances will trigger a fundamental shift in healthcare and beyond. Medicine will continue to become more preventive and more precise. We will be healthier, longer. We have only just begun.
At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics
Illumina 測(cè)序試劑盒 RS-122-2002
產(chǎn)品咨詢